Randomized phase 2 evaluation of bevacizumab versus bevacizumab/fosbretabulin in recurrent ovarian, tubal or peritoneal carcinoma: A gynecologic oncology group study Meeting Abstract
| Authors: | Monk, B.; Sill, M.; Walker, J.; DiSilvestro, P.; Sutton, G.; Tewari, K.; Pajon, E.; Martin, L.; Schilder, J.; Coleman, R.; Balkssoon, J.; Aghajanian, C. |
| Abstract Title: | Randomized phase 2 evaluation of bevacizumab versus bevacizumab/fosbretabulin in recurrent ovarian, tubal or peritoneal carcinoma: A gynecologic oncology group study |
| Meeting Title: | 15th Biennial Meeting of the International Gynecologic Cancer Society |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 24 |
| Issue: | 9 Suppl.4 |
| Meeting Dates: | 2014 Nov 8-11 |
| Meeting Location: | Melbourne, Australia |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2014-11-01 |
| Start Page: | 42 |
| End Page: | 43 |
| Language: | English |
| ACCESSION: | WOS:000344966500033 |
| PROVIDER: | wos |
| PMCID: | PMC4230402 |
| PUBMED: | 25358102 |
| DOI: | 10.1097/01.IGC.0000457075.08973.89 |
| Notes: | Meeting Abstract: IGCSM-1128 -- 4 -- Source: Wos |
